Health
Genome editing to treat human retinal degeneration – EurekAlert
Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness….
IMAGE: Provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications.
view more
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, January 19, 2021–Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges are…
Continue Reading